ISpecimen appoints Evan Cox as VP of Product Management

LEXINGTON, Massachusetts., June 08, 2022 (GLOBE NEWSWIRE) — iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), a global online marketplace that connects scientists in need of biological specimens for medical research with a network of healthcare specimen providers, announced today that the Company has appointed Evan Cox as Vice President of Product Management, effective immediately. In this role, Mr Cox will manage the growth and future development of the iSpecimen Marketplace™ platform.

“Evan’s previous experience planning, developing and delivering technology solutions for leading healthcare organizations will prove essential as we continue to improve and expand our Marketplace offering,” said the Founder. and CEO of iSpecimen, Christopher IanelliMD, Ph.D. to be a real asset to the global medical community.

Before joining iSpecimen, Mr Cox held several key leadership positions at Definitive Healthcare Corp., a healthcare market intelligence provider, most recently as Associate Vice President, where he led the product management team. Previously, he held several product strategy and decision support roles at Change Healthcare, a health technology company, where he focused on artificial intelligence and natural language processing to streamline workflows. existing work. In addition, Mr Cox co-founded DSE Analytics, a company that used natural language processing to integrate qualitative and quantitative information available from Consumer Assessment of Healthcare Providers and Systems (CAHPS) surveys to provide providers with in-depth insight into their health scores. satisfaction. He also served as Senior Product Manager of Data Analytics and Research at Press Ganey Associates and Product Manager of Clinical Data Management at WebMD.

“It’s no secret that precision medicine is driving the demand for more personalized biological sample collections in medical research today,” added Mr Cox. “Harnessing the power of iSpecimen’s advanced technology to accelerate medical discovery is a game-changer for researchers around the world who need samples and data. The key to further optimizing iSpecimen’s Marketplace platform lies in understanding the unique new needs of researchers seeking biological samples and healthcare organizations supplying the samples. I look forward to working alongside management to take iSpecimen’s technology to the next level and solidify the company’s position as a pioneer in the biospecimen supply industry.

About iSpecimen
iSpecimen (Nasdaq: ISPC) provides an online marketplace for human biological specimens, connecting scientists from commercial and nonprofit organizations with healthcare providers with access to patients and samples needed for medical discovery. Proprietary cloud-based technology enables scientists to intuitively search for samples and patients across a federated network of partners from hospitals, laboratories, biobanks, blood centers and other healthcare organizations. For more information, please visit www.ispecimen.com.

For more information, please contact:

Contact Investor
KCSA Strategic CommunicationsAllison Sos[email protected]

Media Contacts
KCSA Strategic CommunicationsRaquel Cona / Shana Marin[email protected]

Source: iSpecimen Inc

2022 GlobeNewswire, Inc., source Press Releases